• OPEN AN ACCOUNT
Indian Indices
Nifty
16,266.15 456.75
(2.89%)
Sensex
54,326.39 1,534.16
( 2.91%)
Bank Nifty
34,276.40 960.75
( 2.88%)
Nifty IT
28,789.40 437.25
( 1.54%)
Global Indices
Nasdaq
11,388.50 -29.65
(-0.26%)
Dow Jones
31,253.13 -236.94
(-0.75%)
Hang Seng
20,717.24 596.56
(2.96%)
Nikkei 225
26,739.03 336.19
(1.27%)
Forex
USD-INR
77.39 -0.06
(-0.07%)
EUR-INR
81.54 0.16
(0.20%)
GBP-INR
96.18 0.07
(0.07%)
JPY-INR
0.60 0.00
(0.56%)

EQUITY - MARKET SCREENER

Adani Enterprises Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
512599
INE423A01024
47.6505998
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ADANIENT
339.44
244520.78
EPS(TTM)
Face Value()
Div & Yield %
6.55
1
0.04
 

ajanta pharma ltd
Ajanta Pharma Ltd - Board Meeting Outcome for Approval For Buy-Back Of Shares
Dec 28,2021
Board of Directors of the Company at its meeting held today i.e. December 28 2021 has inter-alia unanimously approved Buy-back of up to 1120000 fully paid-up Equity Shares of face value of ? 2/- each by the Company (representing 1.29%of the total number of Equity Shares of the Company) at a price of ? 2550/- (Rupees Two Thousand Five Hundred and Fifty only) per Equity Share payable in cash for a total consideration not exceeding ? 285.60 crores (Rupees Two Hundred Eighty Five Crores and Sixty Lakhs only) (excluding transaction costs such as fees brokerage taxes duties etc.) which is not exceeding 10% of the total paid-up equity share capital and free reserves (including securities premium account) as per the audited financial statements of the Company for the financial year ended on March 31 2021 through the Tender Offer route.